Condition
Patient-Reported Outcomes (PRO) clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Patient-Reported Outcomes (PRO) clinical trials that are recruiting, at sites in 2 countries (most in China (1), South Korea (1)). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
Weekly electronic symptom tracking during definitive chemoradiotherapy for lung cancer
This project will test whether weekly electronic questionnaires can map symptom severity and clusters in adults with unresectable stage III non-small cell or limited-stage small cell lung cancer receiving definitive concurrent chemoradiotherapy.
-
Stereotactic body radiotherapy (SABR) for limited metastases
This program tries stereotactic body radiotherapy (SABR) in people with up to five oligometastatic or oligoprogressive cancer lesions to see if it controls disease better, affects symptoms and side effects, and changes ctDNA in the blood.
Related topics
Quick answers
How many Patient-Reported Outcomes (PRO) clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in China (1 trial), South Korea (1 trial). Each study page lists its sites and which ones are recruiting.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.